Effective analysis of Atorvastatin versus in Simvastatin patients with hyperlipidemia.

Journal Title: Journal of Pharmaceutical Sciences and Research - Year 2009, Vol 1, Issue 2

Abstract

 We directly evaluate the safety and dose efficacy of the 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA)reductase inhibitor atorvastatin (X-tor) and simvastatin (Zocor) in hypercholesterolemic patients.Fifty hyperlipidemia patients between the ages of 20 and 75 years with baseline of low-density-lipoprotein(LDL) cholesterol (>160 mg/dl) and triglycerides (>400 mg/dl) received once-daily dosing withatorvastatin 10, 20 mg or simvastatin 10, 20 mg. The efficacy end points were mean percent change inplasma LDL cholesterol, total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C)concentrations from baseline to the end of treatment (week 8). Atorvastatin 10, 20 mg caused significantlygreater reductions in total cholesterol, LDL cholesterol and apolipoprotein B, respectively, than themilligram equivalent doses of simvastatin. On the other hand Atorvastatin 10 mg caused triglycerides andHDL cholesterol were not different between atorvastatin and the other reductase inhibitors except at the 20-mg dose when atorvastatin produced significant changes in triglycerides and HDL cholesterol thansimvastatin. No patient in either treatment group had clinically important elevations in creatinephosphokinase (CPK), alanine aminotransaminase (ALT), or aspartate aminotransaminase (AST). Noserious adverse events were considered associated with treatment. In summary, there is a need for moreeffective total cholesterol and LDL lowering agents to improve treatment aimed at reducing risk ofcoronary heart diseases (CHD). In this trial, atorvastatin was more effective than simvastatin. Atorvastatinshould constitute an important therapeutic option for patients with hyperlipidemia.

Authors and Affiliations

Palanisamy Pasupathi, Saravanan G, Rao Y. Y. , Farook J. , Bakthavathsalam C.

Keywords

Related Articles

The permutation role of fenugreek seeds starch and Gunda glue as<br /> a binder in Paracetamol tablets

Trigonella-foenum graecum (fenugreek) has been reported to contain upto 56.0% starch. The starch was extracted&nbsp;from the seeds of Trigonella-foenum graecum (fenugreek). The entire seeds were subjected to size reducti...

Comparative study of prescribing behaviors of government doctors of teaching hospital and private practitioners in Jhalawar City (Rajasthan)

To compare various aspects of prescribing behaviors of government doctors of teaching hospital and private&nbsp;practitioners. Prescription audit was conducted for a period of 2 months for out patient departments (OPDs)...

Simultaneous UV Spectrophotometric estimtion of Metoclopramide<br /> hydrochloride and Paracetamol in solid dosage form

A simple, specific, accurate, precise and reproducible method has been developed and validated for the simultaneous estimation of metoclopramide hydrochloride and paracetamol in combined dosage form by UV Spectrophotomet...

FACTORS PREDICTIVE OF REMISSION IN STEROID SENSITIVE NEPHROTIC SYNDROME OF PAEDS -A Review

Nephrotic syndrome (NS) is the commonest glomerular disorder in childhood. It is a chronic distressing disorder characterized by heavy proteinuria, hypoproteinaemia, edema and Hyperlipidemia. Nephrotic syndrome is a set...

Evaluation of the antinociceptive properties from Indigofera tinctoria leaves extracts.

&nbsp;The analgesic activity the ethanol extract of Indigofera tinctoria Linn. (Fabaceae) leaves (EEIT) wasinvestigated in chemical models of nociception in mice. EEIT at doses of 100 200 and 400mg/kg p.o producedan inhi...

Download PDF file
  • EP ID EP96901
  • DOI -
  • Views 111
  • Downloads 0

How To Cite

Palanisamy Pasupathi, Saravanan G, Rao Y. Y. , Farook J. , Bakthavathsalam C. (2009). Effective analysis of Atorvastatin versus in Simvastatin patients with hyperlipidemia.. Journal of Pharmaceutical Sciences and Research, 1(2), 16-21. https://europub.co.uk/articles/-A-96901